Ingredient or product comparison
GHK-Cu Cosmetic Research: Study Design Comparison
Before interpreting any peptide study, understand what the methodology can and cannot prove. Isolated fibroblast culture 1–100 nM for 24–72 hours Collagen mRNA (qRT-PCR) or procollagen protein (ELISA) High. Direct measurement of synthesis pathway activation Lo
This source-based comparison does not add ratings or recommend a winner.
- Before interpreting any peptide study, understand what the methodology can and cannot prove.
- Isolated fibroblast culture
- 1–100 nM for 24–72 hours
- Collagen mRNA (qRT-PCR) or procollagen protein (ELISA)
- High. Direct measurement of synthesis pathway activation
- Low. No tissue barriers, no immune interactions
- Cannot assess bioavailability; overestimates potency vs intact skin
- 3D skin equivalent models
- 10–100 μM topical application for 7–14 days
- Collagen density (Sirius Red staining), tissue thickness (histology)
- Moderate. Includes keratinocyte-fibroblast crosstalk and diffusion barriers
- Moderate. Approximates stratum corneum barrier but lacks vasculature
- Expensive; limited to 2-week exposure due to tissue viability
- Excised human skin ex vivo
- 10–500 μM topical application for 24–48 hours
- Penetration depth (confocal microscopy), collagen gene expression
- High for penetration kinetics; moderate for cellular response
- Moderate. Real human tissue but no systemic metabolism
- Tissue viability declines rapidly; no wound healing or remodeling
- Randomized controlled trial (RCT)
- 1–5 mM cream/serum twice daily for 8–24 weeks
- Wrinkle depth (profilometry), elasticity (cutometry), dermis density (ultrasound)
- Low. Correlative only; cannot isolate mechanism
- High. Direct measurement of clinical outcome in target population
- Cannot control for individual genetic variation; expensive; long duration
- Biopsy + immunohistochemistry
- 2–3 mM cream twice daily for 8–12 weeks, then 3mm punch biopsy
- Collagen Type I/III protein (IHC), hydroxyproline content (biochemical assay)
- High. Direct measurement of target protein in human dermis
- High. Proves matrix remodeling in vivo, not just surface changes
- Invasive; small sample size; subjects hesitant to enroll
- Professional Assessment
- RCTs with objective instrumentation (cutometry, ultrasound, profilometry) provide the strongest evidence for clinical efficacy. For mechanism, isolated fibroblast studies paired with biopsy IHC offer the clearest pathway documentation. 3D skin models bridge the gap but remain underutilized.
- The table above shows why citing